Skip to content

Clinical trials

Phase 2 Dermatitis, Atopic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 2 Country / region: Canada Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20092
20134
20142
20157
20166
20175
201812
20199
20203
202110
20226
20238
20244
202513
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Terminated15
Active, not recruiting10
Recruiting7
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer9
LEO Pharma6
GlaxoSmithKline4
Hoffmann-La Roche4
Novartis Pharmaceuticals4
Regeneron Pharmaceuticals4
Janssen Research & Development, LLC3
Sanofi3
ASLAN Pharmaceuticals2
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic98
Eczema41
Dermatitis12
Skin Diseases10
Immune System Diseases5
Pruritus5
Lymphoma, Follicular2
Genetic Diseases, Inborn1
Hypersensitivity1
Hypersensitivity, Immediate1

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.